Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 27, 2010

Premium

Didier Hirsch has been named chief financial officer and senior vice president at Agilent Technologies. Hirsch has been acting CFO and VP of corporate controllership and tax at the company since April. Before joining Agilent, he was director of finance and administration for Hewlett-Packard Europe, Middle East, and Africa, and before that he held a similar post in HP's Asia Pacific business.


Anath Shalev has been named the director of the University of Alabama at Birmingham Comprehensive Diabetes Center, effective Oct. 1. Shalev also will be a professor of medicine in the division of endocrinology, diabetes, and metabolism at UAB. She currently is director of endocrinology, diabetes and metabolism research in the department of medicine at the University of Wisconsin-Madison.

Shalev's laboratory uses array technology to examine potential targets for therapeutic interventions to block apoptosis of pancreatic beta cells. Shalev earned her medical degree from the University of Basel in Switzerland in 1993 and completed a post-graduate scholarship in experimental medicine and biology at the University of Zurich and a research fellowship at Harvard University.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more